This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Mosaic Health asks for another chance in US antitrust case over diabetes treatments

( October 3, 2022, 22:31 GMT | Official Statement) -- MLex Summary: Mosaic Health asked a US federal judge to allow it to bring amended claims in a case accusing Sanofi-Aventis, Eli Lilly, Novo Nordisk, and Astrazeneca Pharmaceuticals of conspiring to retract a long-standing discount for safety-net hospitals and clinics. US District Judge Elizabeth A. Wolford dismissed Mosaic’s claims in September. It said that its proposed second amended complaint addresses issues identified by the court through abundant and detailed data and facts. “The SAC cites government-compiled data now available demonstrating exactly how similar defendants’ restrictions were, with those restrictions each doing immense damage to previously existing drug discounts.”See documents below. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections